Coronary/Structural Heart

XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease

Positive Phase 1 results reported at the American Association for Thoracic Surgery (AATS) and the American Society of Gene and Cell Therapy (ASGCT) revealed XC001 is well tolerated at all dose levels Phase I data support XC001 therapeutic effect and potential dose response Topline Phase 2 data readout expected in […]

BayCare Receives Recognition for its Minimally Invasive Transcatheter Valve Procedures

CLEARWATER, Fla., June 23, 2022 /PRNewswire/ — The structural heart programs at BayCare’s Morton Plant Hospital in Clearwater and St. Joseph’s Hospital in Tampa recently received the American College of Cardiology (ACC) Transcatheter Valve Certification. The certification recognizes each program’s expertise and commitment to excellence in treating patients receiving transcatheter valve repair and replacement procedures. “Our […]

First American Patient Treated with VenusP-Valve™ Under Compassionate Use

HANGZHOU, China, June 22, 2022 /PRNewswire/ — VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as “Venus Medtech”), recently completed its first compassionate use at University of Virginia Advanced Cardiac Valve Center in the U.S. The procedure was performed at the Center by Professor Scott Lim’s team under […]

New Understanding of Congenital Heart Disease Progression Opens Door to Improved Treatment Options

Scientists develop a roadmap to future personalized medicine for heart defects that develop before birth HOUSTON, June 22, 2022 /PRNewswire/ — A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered new insights into the mechanisms underlying the progression of congenital heart disease (CHD) ― a spectrum […]

Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska

Press release Malmö, Sweden, June 22, 2022 Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Acarix continues its US expansion by partnering with Strategic Health AK, a healthcare provider covering tribal and rural areas of Alaska. Acarix has received initial orders of CADScor®Systems to […]

CAPTION HEALTH LAUNCHES FIRST IN-HOME ULTRASOUND SERVICE FOR HEART HEALTH: CAPTION CARE™

Caption Care creates access to echos in partnership with Portamedic’s nationwide mobile clinician network to improve heart health and lower the cost of care BRISBANE, Calif., June 21, 2022 /PRNewswire/ — Caption Health, the AI leader that enables earlier disease detection, today unveiled Caption Care™:  America’s first in-home heart wellness assessment and low-cost echo […]

GE Healthcare Introduces Wireless Patient Monitoring Solution to Help Clinicians Detect Early Patient Deterioration

Continuous monitoring using wearable sensors in general hospital wards may help detect patient deterioration earlier than traditional spot check methods and assist clinicians in improving patient outcomes1. Wireless monitoring allows earlier patient mobilization, a key indicator for recovery, particularly post-surgery2. This innovative technology was developed at GE Healthcare’s global center […]

Conformal Medical Announces Launch of CONFORM Pivotal Trial

Study to support U.S. FDA approval of the novel CLAAS® implant forleft atrial appendage occlusion (LAAO) and stroke prevention NASHUA, N.H., June 17, 2022 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation LAAO technology, today announced the launch of the CONFORM pivotal trial with the enrollment of the first patients at two U.S. sites. The […]

SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology

TEL AVIV, Israel, June 20, 2022 /PRNewswire/ — SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approval for its “REDUCED1” Pilot study to treat Resistant Hypertension Patients with Renal […]

Cytokinetics Provides Regulatory Update for Omecamtiv Mecarbil

Recent Company Submission in Response to FDA Request Extends PDUFA Date SOUTH SAN FRANCISCO, Calif., June 17, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that, in response to a request from the U.S. Food and Drug Administration (FDA), the company recently provided additional pharmacokinetic analyses of omecamtiv mecarbil related […]